Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 1-14

  Whitnall, Mark H ^a   Elliott, Thomas B ^a   Harding, Rita A ^a   Inal, Cynthia E ^a   Landauer, Michael R ^a   Wilhelmsen, Catherine L ^a   McKinney, Luann ^a   Miner, Venita L ^a   Jackson III, William E ^a   Loria, Roger M ^b   Ledney, G David ^a   Seed, Thomas M ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Androst 5 ene 3 beta, 17 beta diol; Experimental radiation injuries; Gram negative bacterial infections; Hematopoiesis; Ionizing radiation; Klebsiella pneumoniae; Neutropenia; Prasterone

Indexed keywords

ANDROSTENEDIOL; PRASTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; COLONY FORMING UNIT M; FEMALE; GAMMA IRRADIATION; GRAM NEGATIVE BACTERIUM; HEMATOPOIESIS; IMMUNE FUNCTION TEST; INFECTION RESISTANCE; IONIZING RADIATION; KLEBSIELLA PNEUMONIAE; LYMPHOCYTE ACTIVATION; MOUSE; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT; THROMBOCYTE; THROMBOCYTOPENIA; VIRUS INFECTION;

ANDROSTENEDIOL; ANIMALS; BACTERIAL INFECTIONS; BLOOD PLATELETS; FEMALE; GAMMA RAYS; HEMATOPOIESIS; MICE; NEUTROPHILS; RADIATION-PROTECTIVE AGENTS;

EID: 0033955972     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00059-4     Document Type: Article

References (71)

1. Fliedner T.M., Nothdurft W., Heit H. Biological factors affecting the occurrence of radiation syndromes. Broerse J.J., MacVittie T.J. Response of different species to total body irradiation. 1984;209-219 Martinus Nijhoff Publishers, Boston.
2. Hendry J.H., Feng-Tong Y. Response of bone marrow to low LET irradiation. Hendry J.H., Lord B.I. Radiation toxicology: bone marrow and leukaemia. 1995;91-116 Taylor and Francis, London.
3. Mauch P., Constine L., Greenberger J., Knospe W., Sullivan J., Liesveld J.L., Deeg H.J. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1319-1339.
4. Elliott T.B., Madonna G.S., Ledney G.D., Brook I. Combined therapy for postirradiation infection. Microecol. Ther. 19:1989;105-108.
5. Madonna G.S., Ledney G.D., Elliott T.B., Brook I., Ulrich J.T., Myers K.R., Patchen M.L., Walker R.I. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect. Immun. 57:1989;2495-2501.
6. Patchen M.L., MacVittie T.J., Solberg B.D., D'Alesandro M.M., Brook I. Radioprotection by polysaccharides alone and in combination with aminothiols. Adv. Space Res. 12:1992;(2)233-(2)248.
7. Peterson V.M., Adamovicz J.J., Elliott T.B., Moore M.M., Madonna G.S., Jackson W.E. III, Ledney G.D., Gause W.C. Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J. Immunol. 153:1994;2321-2330.
8. Fedorocko P., Macková O. Combined modality radioprotection: enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and indomethacin. Int. J. Immunopharmacol. 18:1996;329-337.
9. Neta R., Oppenheim J.J., Douches S.D. Interdependence of the radioprotective effects of human recombinant interleukin 1α, tumor necrosis factor α, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 140:1988;108-111.
10. Waddick K.G., Song C.W., Souza L., Uckun F.M. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood. 77:1991;2364-2371.
11. MacVittie T.J., Weiss J.F., Browne D. Advances in the treatment of radiation injuries. 1996;Pergamon/Elsevier Science Inc, Tarrytown, NY.
12. Kumar K.S., Srinivasan V., Palazzolo D., Kendrick J.M., Clark E.P. Synergistic protection of irradiated mice by a combination of iloprost and misoprostol. Honn K.V., Nigam S., Marnett L.J. Eicosanoids and other bioactive lipids in cancer, inflammation, and radiation injury 2. 1997;831-839 Plenum Press, New York.
13. Ben-Nathan D., Lachmi B., Lustig S., Feuerstein G. Protection by dehydroepiandrosterone in mice infected with viral encephalitis. Arch. Virol. 120:1991;263-271.
14. Loria R.M., Padgett D.A. Androstenediol regulates systemic resistance against lethal infections in mice. Arch. Virol. 127:1992;103-115.
15. Loria R.M., Padgett D.A. Mobilization of cutaneous immunity for systemic protection against infections. Ann. N. Y. Acad. Sci. 650:1992;363-366.
16. Rasmussen K.R., Martin E.G., Healey M.C. Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. J. Parasitol. 79:1993;364-370.
17. Araneo B., Daynes R. Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology. 136:1995;393-401.
18. H2 immune response. Ann. N. Y. Acad. Sci. 774:1995;323-325.
19. Gianotti L., Alexander J.W., Fukushima R., Pyles T. Steroid therapy can modulate gut barrier function, host defense, and survival in thermally injured mice. J. Surg. Res. 62:1996;53-58.
20. Padgett D.A., Loria R.M., Sheridan J.F. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J. Neuroimmunol. 78:1997;203-211.
21. Suitters A.J., Shaw S., Wales M.R., Porter J.P., Leonard J., Woodger R., Brand H., Bodmer M., Foulkes R. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase. Immunology. 91:1997;314-321.
22. Carr D.J. Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J. Neuroimmunol. 89:1998;160-167.
23. Daigle J., Carr D.J. Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type 1 IFN production. J. Immunol. 160:1998;3060-3066.
24. Yen S.S.C., Morales A.J., Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann. N. Y. Acad. Sci. 774:1995;128-142.
25. Danenberg H.D., Alpert G., Lustig S., Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob. Agents Chemother. 36:1992;2275-2279.
26. Araghi-Niknam M., Zhang Z., Jiang S., Call O., Eskelson C.D., Watson R.R. Cytokine dysregulation and increased oxidation is prevented by dehydroepiandrosterone in mice infected with murine leukemia retrovirus. Proc. Soc. Exp. Biol. Med. 216:1997;386-391.
27. Hernandez-Pando R., De La Luz Streber M., Orozco H., Arriaga K., Pavon L., Al-Nakhli S.A., Rook G.A. The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology. 95:1998;234-241.
28. Inserra P., Zhang Z., Ardestani S.K., Araghi-Niknam M., Liang B., Jiang S., Shaw D., Molitor M., Elliott K., Watson R.R. Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice. Proc. Soc. Exp. Biol. Med. 218:1998;76-82.
29. Kimura M., Tanaka S-I., Yamada Y., Kiuchi Y., Yamakawa T., Sekihara H. Dehydroepiandrosterone decreases serum tumor necrosis factor-α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology. 139:1998;3249-3253.
30. Moynihan J.A., Callahan T.A., Kelley S.P., Campbell L.M. Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4, and interferon-gamma production in vitro. Cell. Immunol. 184:1998;58-64.
31. Padgett D.A., Loria R.M. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J. Neuroimmunol. 84:1998;61-68.
32. MacVittie T.J., Farese A.M. Experimental approaches to treatment of radiation-induced hemopoietic injury. Hendry J.H., Lord B.I. Radiation toxicology: bone marrow and leukaemia. 1995;141-194 Taylor & Francis, London.
33. Patchen M.L. Single and combination cytokine therapies for the treatment of radiation-induced hemopoietic injury. Adv. Biosci. 94:1996;21-36.
34. Neta R. Modulation of radiation damage by cytokines. Stem Cells Dayt. 15:(Suppl. 2):1997;87-94.
35. Sonka J., Strakova M. Survival of irradiated mice pretreated by dehydroepiandosterone. Agressologie. 11:1970;421-426.
36. Padgett D.A., Loria R.M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol. 153:1994;1544-1552.
37. McLachlan J.A., Serkin C.D., Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156:1996;328-335.
38. Risdon G., Kumar V., Bennett M. Differential effects of dehydroepiandrosterone on murine lymphopoiesis and myelopoiesis. Exp. Hematol. 19:1991;128-131.
39. Hendry J.H., Lord B.I. Radiation toxicology: bone marrow and leukaemia. 1995;Taylor & Francis Inc, London.
40. Myska JC, Adams TL, Bhatt RC, Broom JG, Pitcher CD, Sharpnack FM II, St. John TJ, Torres BA, Vavrina G, Gerstenberg HM. Arrays for use at the cobalt irradiation facility. AFRRI Technical Report 97-2. Armed Forces Radiobiology Research Institute, September, 1997.
41. A protocol for the determination of absorbed dose from high-energy photon and electron beams. Med. Phys. 10:1983;741-771.
42. Hammer J.G., Harris H.A., Komm B.S., Goodwin T., Goldberg K., Van Winkle T. Comparison of gross and histologic effects of six vehicles for subcutaneous injection of hydrophobic steriod mimetic compounds in rats. Contemp. Top. Lab. Anim. Sci. 35:1996;72. [abstract].
43. Seed T.M., Fritz T.E., Tolle D.V., Poole C.M., Lombard L.S., Doyle D.E., Kaspar L.V., Cullen S.M., Carnes B.A. Survival patterns and hemopathological responses of dogs under continuous gamma irradiation. Broerse J.J., MacVittie T.J. Response of different species to total body irradiation. 1984;137-159 Martinus Nijhoff Publishers, Boston.
44. Fritz T.E., Seed T.M., Tolle D.V., Lombard L.S. Late effects of protracted whole-body irradiation of beagles by cobalt-60 gamma rays. Thompson R.C., McGaffey J.A. Life-span radiation effects studies in animals: what can they tell us? 1986;116-141 Office of Scientific and Technical Information, United States Department of Energy, Washington, DC.
45. Seed T.M., Kaspar L.V. Probing altered hematopoietic progenitor cells of preleukemic dogs with JANUS fission neutrons. Radiat. Res. 128:1991;S81-S86.
46. Lord B.I., Hendry J.H. Radiation toxicology: bone marrow and leukaemia. Hendry J.H., Lord B.I. Radiation toxicology: bone marrow and leukaemia. 1995;1-21 Taylor & Francis, London.
47. Vial T., Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Safety. 13:1995;371-406.
48. Araneo B.A., Shelby J., Li G.Z., Ku W., Daynes R.A. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch. Surg. 128:1993;318-325.
49. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.Z., Ryu S.Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 150:1993;5219-5230.
50. Kim H.R., Ryu S.Y., Kim H.S., Choi B.M., Lee E.J., Kim H.M., Chung H.T. Administration of dehydroepiandrosterone reverses the immune suppression induced by high dose antigen in mice. Immunol. Invest. 24:1995;583-593.
51. Seed T.M., Cullen S.M., Kaspar L.V., Tolle D.V., Fritz T.E. Hemopathologic consequences of protracted gamma irradiation: alterations in granulocyte reserves and granulocyte mobilization. Blood. 56:1980;42-51.
52. Fujikawa H., Okura F., Kuwano Y., Sekizawa A., Chiba H., Shimodaira K., Saito H., Yanaihara T. Steroid sulfatase activity in osteblast cells. Biochem. Biophys. Res. Commun. 231:1997;42-47.
53. Lea-Currie Y.R., Wu S.M., McIntosh M.K. Effects of acute administration of dehydroepiandrosteron-sulfate on adipose tissue mass and cellularity in male rats. Int. J. Obes. Relat. Metab. Disord. 21:1997;147-154.
54. Nakashima N., Haji M., Sakai Y., Ono Y., Umeda F., Nawata H. Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts. Metabolism. 44:1995;543-548.
55. Meikle A.W., Daynes R.A., Araneo B.A. Adrenal androgen secretion and biologic effects. Endocrinol. Metab. Clin. North. Am. 20:1991;381-400.
56. Mohan P.F., Jacobson M.S. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am. J. Med. Sci. 306:1993;10-15.
57. Whitcomb J.M., Schwartz A.G. Dehydroepiandrosterone and 16 alpha-Br-epiandrosterone inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes. Carcinogenesis. 6:1985;333-335.
58. Pascale R., Garcea R., Ruggiu M.E., Daino L., Frassetto S., Vannini M.G., Cozzolino P., Lenzerini L., Feo F., Schwartz A.G. Decreased stimulation by 12-O-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. Carcinogenesis. 8:1987;1567-1570.
59. Suzuki T., Suzuki N., Daynes R.A., Engleman E.G. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 61:1991;202-211.
60. Meikle A.W., Dorchuck R.W., Araneo B.A., Stringham J.D., Evans T.G., Spruance S.L., Daynes R.A. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol. 42:1992;293-304.
61. Okabe T., Haji M., Takayanagi R., Adachi M., Imasaki K., Kurimoto F., Watanabe T., Nawata H. Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J. Clin. Endocrinol. Metab. 80:1995;2993-2996.
62. Maradny E., Kanayama N., Maehara K., Kobayashi T., Terao T. Dehydroepiandrosterone sulfate potentiates the effect of interleukin-8 on the cervix. Gynecol. Obstet. Invest. 42:1996;191-195.
63. Waxman D.J. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J. Endocrinol. 150:1996;S129-S147.
64. Peters J.M., Zhou Y.C., Ram P.A., Lee S.S., Gonzalez F.J., Waxman D.J. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Molec. Pharmacol. 50:1996;67-74.
65. Loria R.M., Padgett D.A., Huynh P.N. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J. Endocrinol. 150:1996;S209-S220.
66. Morfin R., Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J. Steroid Biochem. Mol. Biol. 50:1994;91-100.
67. Frenkel R.A., Slaughter C.A., Orth K., Moomaw C.R., Hicks S.H., Snyder J.M., Bennett M., Prough R.A., Putnam R.S., Milewich L. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J. Steroid Biochem. 35:1990;333-342.
68. Yamada J., Sakuma M., Ikeda T., Fukuda K., Suga T. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta. 1092:1991;233-243.
69. Coffey D.S. Androgen action and the sex accessory tissues. Knobil E., Neill J. The physiology of reproduction. 1988;1081-1119 Raven Press, New York. [Chapter 24].
70. Angele M.K., Ayala A., Cioffi W.G., Bland K.I., Chaudry I.H. Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am. J. Physiol. 274:1998;C1530-C1536.
71. National Research Council. Guide for the care and use of laboratory animals. 1996;National Academy Press, Washington, DC.